Policy & Regulation

EU medicines regulators agree AI workplan

Read more

Editorial: Stand up for the FDA

Read more

EU public policy on AI

Read more

Achieving federated analysis through partnership, by Philip Quinlan

Read more

Commentary, Real-world data should drive obesity drug use, by Femida Gwadry-Sridhar

Read more

EU guides on the use of AI in medicines regulation

Read more

GLP-1 agonist shortages set to continue

Read more

Efpia: A competitive strategy for the future

Read more

More advanced planning needed for antimicrobials

Read more

New antibiotics pass regulatory hurdles

Read more